The IPKat

FEBRUARY 24, 2022

Annual Conference on EU Law in the Pharmaceutical Sector 2022 (Brussels/online) The first event is the Annual Conference on EU Law in the Pharmaceutical Sector 2022 , which will take place in hybrid format (Brussels and online) on 17 and 18 March 2022.

Intellectual Property Law 57

Intellectual Property Law Intellectual Property IP Patent Law 57

SpicyIP

SEPTEMBER 11, 2023

Whether it is South Asian Basmati Brawls, the much-to-tread trail of transparency, the Statements of Patent (Non-)Working, or the Indian “Bayh Dole” Bill, some stories never cease to beguile us. He wrote detailed posts on this topic later here and here. Here we go: 1. Both of these questions were answered in the negative.

IP 105

IP Reporting Plagiarism Government 105

The IPKat

JULY 31, 2023

This year’s summit follows the launch of the Unified Patent Court (UPC) and will inter alia allow participants to understand the industry’s reaction to the new court system and have candid discussions with European life science intellectual property experts. The IPKat has also negotiated a special discount for readers.

IP 52

IP Editing Intellectual Property Patent 52

SpicyIP

JULY 9, 2021

We’re pleased to inform you that The Journal of the Patent and Trademark Office Society is inviting submissions for Volume 102 of the journal. For further deatils, please see the announcement below: Call for Submissions: The Journal of the Patent and Trademark Office Society (Vol. Logo of Patent & Trademark Office Society.

Journalism 105

Journalism Intellectual Property Law Trademark Intellectual Property 105

IPilogue

NOVEMBER 24, 2021

As I searched for a topic for this blog post, I encountered a common theme: the Canadian technology sector is constantly asking for more action from the Canadian government aimed at fostering innovation in the community. The Pharmaceutical Sector. In their Innovation Report Card 2021 , Canada earned a grading level of D in patents.

Intellectual Property 105

Intellectual Property Government Inventor Blogging 105

The IPKat

MAY 12, 2023

So she was excited to learn that this year's C5 Pharma and Biotech Patent Litigation Conference is being held in Amsterdam on 23-24 May 2023. The AmeriKat is particularly looking forward to the session on "Managing the Implications of the EPO's Decisions in BOA Referral G 2/21" and, as ever, her favorite favorite topic - SPCs.

Litigation 57

Litigation Patent Reporting 57

SpicyIP

JANUARY 1, 2024

The Assistant Controller of Patents and Designs – A Reasoned Judgement or Inherently Contradictory? Image from here Despite noting the lack of clarity on the concepts of “technical effect” and “contribution” in the context of the patentability of CRIs, the DHC in Microsoft v. Other Posts Microsoft Technology Licensing LLC V.

Intellectual Property 105

Intellectual Property IP Licensing Copyright 105

The IP Law Blog

JULY 15, 2021

CLS Bank Int’l , which involve the limits on patent eligibility under 35 U.S.C. § For example, in Alice, the court stated “[t]he ‘abstract ideas’ category embodies the longstanding rule that an idea of itself is not patentable.” Patent attorneys and inventors are often left to guess whether a particular invention is patent-eligible.

Law 109

Law Patent Invention Intellectual Property 109

The IPKat

OCTOBER 20, 2021

Patents The IP Helpdesk blog informed on compulsory licensing of patents in India. The author reviewed several cases where compulsory licenses were granted by Indian authorities, including those in the field of pharmaceuticals [see also an earlier post on this topic on The IPKat ].

Blogging 67

Blogging IP Registration Licensing 67

IPilogue

NOVEMBER 23, 2021

Patent and Trademarks Office (USPTO) closed the public comment period on the contentious topic of patent eligibility. To understand these varying opinions, it is important to examine patent eligibility’s current state, recent changes, and what changes could be made to the patent eligibility laws. Calls for Reform.

Patent 105

Patent Invention Intellectual Property Inventor 105

Patently-O

JULY 8, 2021

At the behest of several leading Senators, the USPTO has begun a study on the “Current State of Patent Eligibility Jurisprudence.” The agency would like input from various stakeholders, including inventors, owners, investors, licensees, users, and patent attorneys.

Patent Prosecution 96

Patent Prosecution Intellectual Property Inventor Invention 96

Patently-O

APRIL 28, 2022

The court in Ariad explained that a “a vague functional description” may be insufficient as it likely describes the unpatentable problem rather than a patentable solution. Ariad Pharmaceuticals et al. I suggest that patent examiners are primarily focusing on Number 1, New Matter Written Description. 3d 1336 (Fed.

Inventor 105

Inventor Invention Art Litigation 105

IPilogue

DECEMBER 3, 2021

As part of the course requirements, students were asked to write a blog on a topic of their choice. This prohibition originated from an old provision of the Patent Act (Section 41) interpreted by the Supreme Court of Canada in Tennessee Eastman. The second claim specifies a fixed dosage rather than a range and is therefore patentable.

Intellectual Property Law 106

Intellectual Property Law Patent Infringement Intellectual Property Law 106

The IPKat

JULY 4, 2021

Conferences, webinars On July 8, the Union of European Practitioners in Intellectual Property (UNION-IP) is organising an online discussion with Lisa Jorgenson, Deputy Director General, Patents and Technology Sector (WIPO), who will talk about the latest news and developments from WIPO. Registration is available here.

Intellectual Property 70

Intellectual Property Journalism Social Media Intellectual Property Law 70

The IPKat

NOVEMBER 14, 2022

However the two recent posts of this very same blog, one on the preliminary opinion of EBA on plausibility (G2/21, here ), the other on the requisite of sufficiency of disclosure for a first medical use patent (T0424/21, here ) have removed any doubt on whether or not to try and cover it.

IP 76

IP Marketing Marketing Confidentiality 76

SpicyIP

OCTOBER 26, 2022

After a few sessions on conceptual and theoretical ideas around IP, this set of sessions will now take the class on a different not-so-theoretical topic and deliberates upon IP issues that crop up around clinical trial test data, drug innovation, Indian drug regulatory regulation etc. Prof Antilegend’s classes are back! Confused face).

IP 118

IP Invention Patent Marketing 118

The IPKat

SEPTEMBER 4, 2023

The patent ( EP (UK) 1613296 ) claimed safinamide in combination with levodopa for the manufacture of a medicament for the treatment of Parkinson's disease. Case Background: XADAGO Newron v Comptroller related to Newron pharmaceutical UK SPC application for its branded Parkinson's disease drug XADAGO ( SPC/GB15/046 ).

Art 117

Art Marketing Marketing Patent 117

LexBlog IP

JULY 15, 2021

CLS Bank Int’l , which involve the limits on patent eligibility under 35 U.S.C. § For example, in Alice, the court stated “[t]he ‘abstract ideas’ category embodies the longstanding rule that an idea of itself is not patentable.” § 101. §101. .”

Law 52

Law Invention Patent Intellectual Property 52

SpicyIP

OCTOBER 19, 2023

Yes … the current level of accessibility wasn’t always the case in the IP domain neither in trademark nor in patent domain! Whether it’s the IPAB website or the Indian patent website , the recurrent issue of non-functional platforms doesn’t surprise us anymore. In the post, Prof. where Prof.

Patent Prosecution 59

Patent Prosecution Reporting Blogging Patent 59

Bio Law Blog

NOVEMBER 15, 2021

District Court for the District of Delaware granted Elysium’s motion for summary judgment that two ChromaDex formulation patents were directed to patent-ineligible subject matter under 35 U.S.C. § The two ChromaDex patents, U.S. Patent Nos. § 101. ChromaDex, Inc. Elysium Health, Inc. Civil Action No.

Patent 52

Patent Invention Litigation Contracts 52

Patently-O

NOVEMBER 29, 2023

Jordan is a third-year law student at the University of Missouri and a registered patent agent. Article III standing remains a hot topic at all levels of federal litigation and across many different areas of law. 10,149,820 (the ‘820 patent). Allgenesis petitioned for IPR of all eleven claims of the ’820 patent.

Art 49

Art Business Patent Settlement 49

Patently-O

OCTOBER 5, 2021

The USPTO is seeking comments on “the state of patent eligibility jurisprudence” and how eligibility law impacts both innovation and investment-in-innovation. and (2) Is patent eligibility a question of law for the court or a question of fact for the jury? The deadline for submissions is October 15, 2021. Berkheimer, No.

Patent 102

Patent Intellectual Property Invention Inventor 102

Patently-O

MAY 23, 2022

Prior to the mid-1990s, patent litigation took place in district court silos. District judges managed these cases based on their general litigation background, which rarely extended to patent cases. Experienced patent litigators, many of whom also prosecuted patents, brought their technical and litigation experience to the table.

Patent 67

Patent Litigation Intellectual Property Intellectual Property Law 67

SpicyIP

NOVEMBER 8, 2023

Since living cells and products of nature are often involved in these inventions, clarity regarding patent eligibility is becoming more important. The discovery, development and patenting of biologics has been historically tied to the ‘product of nature’ question under patent law. CLS Bank Int’l. Kibow Biotech Inc.,

Invention 69

Invention Patent Art Patent Law 69

The IPKat

JULY 25, 2021

The Tiroler Adler may fly, but the Tiroler Katze prefers to snooze The IPKat served as a platform for reporting and debate on a range of topics last week, not least through the range of guest posts published. and Yogesh Pai arguing that the exercise is futile and Murali Neelakantan and Siva Thambisetty responding.

Reporting 76

Reporting Intellectual Property Confidentiality Privacy 76

The IPKat

JUNE 25, 2021

This year’s highlights include: 20+ speakers, including experts from WIPO, Nokia, Cisco, Sisvel, ETSI, Qualcomm, Bird & Bird and Ericsson Focus on how to navigate the rapidly changing standards and patents legal landscape IPKat readers are entitled to a 15% discount in the registration fee using the code FKW83298IPKE.

Registration 52

Registration IP Law Patent 52

The IPKat

OCTOBER 2, 2023

We are now awash with companies claiming to provide LLM software capable of drafting, prosecuting and challenging patents. This post will instead focus on the potential short to medium term impact of LLMs on the patent profession. Patent drafts and office actions follow a distinct format and style.

Patent Drafting 73

Patent Drafting Patent Invention Technology 73

Patently-O

SEPTEMBER 26, 2022

It is time to pick-up our consideration of Supreme Court patent cases for the 2022-2023 term. Bottom line, no patent cases were decided by the Court in the 2021-2022 term and none were granted certiorari for the new term starting this week. Of the 17 pending patent-focused petitions, 13 are set to be decided at the long conference.

Patent Law 126

Patent Law Law Patent Invention 126

The IPKat

FEBRUARY 10, 2023

life sciences conference before the UPC by Gabriele Girardello At the end of last month this Katfriend had the opportunity to attend a conference in Amsterdam devoted to ‘Pharma & Biotech Patent Litigation Europe’ (programme here ). The conference has become an annual event. A litigator Kat whispering in the ears of a poor UPC Judge (ph.

Litigation 70

Litigation Reporting Patent Invention 70

SpicyIP

AUGUST 15, 2021

Topical Highlight. In this post , Rahul Bajaj and Praharsh Gour analayse the underutilisation of Indian patent law’s robust flexibilities to promote patient interest. They discuss the best potential route for a compulsory license under the Indian Patents Act, and the ways in which the government can make the best use of it.

Licensing 83

Licensing Government Reporting Patent Law 83

The IPKat

OCTOBER 25, 2022

EVENTS 27 October 2022 | 4iP Council: webinar " IP Waiver in pandemic times " (online) This webinar provides an overview of the challenges during the pandemic and the impact of the TRIPS waiver on innovation, global public health, global collaboration, the patent system, etc. Registrations are available here. Registration is available here.

Intellectual Property 67

Intellectual Property Registration IP Technology 67

Larson & Larson

NOVEMBER 30, 2022

Crafting a patent application is a key step in helping to ensure that your business is safe from outside competition. In this post, we’ll take a deep dive into what goes into drafting a patent application and how to make the most of your efforts while doing so. What can and cannot be patented. How to write a patent application.

Patent Application 40

Patent Application Patent Invention Business 40

The IPKat

FEBRUARY 14, 2022

A Kat trying to negotiate an early spring with Mother Nature Conferences and events EPO Tech Day 2022 - 16 February 2022 On 16 February 2022, from 1:00pm to 5:15pm (CET), the European Patent Office (EPO) will celebrate Tech Day 2022 with the online event "Technologies of Transformation: Patenting in an era of global challenges and opportunities".

Intellectual Property 52

Intellectual Property Registration Patent Infringement Television 52

SpicyIP

JULY 5, 2021

Topical Highlight. In this post , we informed our readers about an announcement from LexisNexis Intellectual Property that LexisNexis Reed Tech will continue to provide patent data and document management services to the USPTO for the next 10 years. The Bombay High Court in Franco Indian Pharmaceuticals Pvt. Golden Tobacco Ltd.

Intellectual Property 105

Intellectual Property Trademark Licensing Copyright 105

SpicyIP

NOVEMBER 6, 2023

However, during discussions, these two topics have been the main points of disagreement. Additionally, it encourages patent holders to temporarily waive or manage, as appropriate, payment royalties made by developing country manufacturers. Third parties would accordingly require access to both patents and associated trade secrets.

IP 59

IP Intellectual Property Publishing Technology 59

SpicyIP

AUGUST 2, 2021

Topical Highlight. Parliamentary Standing Committee Report on IPR: Tipping the Scales of Patent Law? Continuing our posts on the Parliamentary Standing Committee Report, I wrote a II-part post on the Report’s recommendations on patent law reform. Part I and II. Other Posts.

Reporting 116

Reporting Designs Design Copyright 116

The IPKat

OCTOBER 2, 2023

evidence that was not public before the filing date of the patent in suit and was filed after that date) as proof that the problem has been solved (i.e. Application of G 2/21 outside of biotech There is currently some debate over the potential relevance of G 2/21 outside the setting of biotech and pharmaceutical inventions.

Invention 70

Invention Art Publishing Patent 70